$30.80
0.401.32%
At close: -
$30.80
0.000500.00%
After Hours: Dec 20, 4:01 PM EDT
Comments
Loading...
Latest news for NovoCure (NASDAQ:NVCR) Stock
NovoCure Stock (NASDAQ: NVCR)
Categories: All
Sunday, December 15, 2024
Friday, December 13, 2024
Sunday, December 08, 2024
Tuesday, December 03, 2024
Monday, December 02, 2024
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Dow Dips 150 Points; ISM Manufacturing PMI Tops Estimates
- HC Wainwright & Co. Reiterates Buy on NovoCur...
- XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
- NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients
- This Gap Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
- NocoCure shares are trading higher after the ...
- Novocure Says Phase 3 PANOVA-3 Trial Met Its ...
- Navigating 5 Analyst Ratings For NovoCure
- Evercore ISI Group Upgrades NovoCure to Outpe...
Thursday, November 21, 2024
Thursday, October 31, 2024
Wednesday, October 30, 2024
Wednesday, October 16, 2024
- Deep Dive Into NovoCure Stock: Analyst Perspectives (4 Ratings)
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NovoCure shares are trading higher after the ...
- US Stocks Could Open Narrowly Mixed After Tuesday's Chip Sell-Off, Bitcoin Heads To $68K, Oil Slips
- FDA Approves NovoCure's Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients
- HC Wainwright & Co. Upgrades NovoCure to Buy,...